http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016540796-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
filingDate 2014-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2016540796-A
titleOfInvention Indazole compounds as 5-HT4 receptor agonists
abstract The present invention relates to novel indazole compounds of formula (I) wherein R 1 is alkyl or cycloalkyl; A and B are as in formula (II)) (the stereoisomers thereof and those Including pharmaceutically acceptable salts thereof. The invention also relates to methods for producing such compounds and pharmaceutical compositions comprising such compounds. The compounds of the present invention are useful in the treatment of various diseases associated with 5-hydroxytryptamine 4 (5-HT 4 ) receptor agonists.
priorityDate 2013-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013042135-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007516278-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013519630-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467354070
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426047072
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467907680
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424401521
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19082793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4736391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467220300
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467219166
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467440288

Total number of triples: 48.